NanoViricides, Inc. Press Releases

NNVC 
$2.6
*  
0.09
3.35%
Get NNVC Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading NNVC now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
NanoViricides Reports that the FluCide® Candidate was found to be Very Safe in cGLP-like Safety and Toxicology Study in Rats Performed by BASi
1/23/2015 7:00:00 AM - PR Newswire
▼-9.41 % Price Change since this news event. The Volume Ratio is 1.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NanoViricides Reports That It Has Shipped anti-Ebola Drug Candidates For Testing to a BSL-4 Hi-Security Biocontainment Laboratory
1/22/2015 7:00:00 AM - PR Newswire
▲4.00 % Price Change since this news event. The Volume Ratio is 7.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NanoViricides, Inc.'s Executive Officers Report Insider Purchases of Common Stock
1/21/2015 7:00:00 AM - PR Newswire
▼-1.52 % Price Change since this news event. The Volume Ratio is 1.53.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NanoViricides, Inc. Completes Purchase of cGMP-compliant Pilot Production Facility
1/7/2015 7:30:00 AM - PR Newswire
▼-0.38 % Price Change since this news event. The Volume Ratio is 1.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NanoViricides Says Injectable FluCide™ Selected in Top Ten Project to Watch - Presentation Today at the Therapeutics Area Partnerships Meeting in Boston
11/20/2014 2:15:00 AM - Business Wire


NanoViricides CEO, Eugene Seymour, MD, MPH, Invited to Discuss the Current Ebola Outbreak on Fox Business News at 9PM EDT Tonight
11/18/2014 2:58:00 AM - Business Wire


NanoViricides, Inc. Files Quarterly Report - Reports Further Improved Strong Cash Position Sufficient for Clinical Trials of its First Two Drug Candidates
11/17/2014 7:00:00 AM - Business Wire